[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342213-105":59,"doc-detail-342213-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","potential-role-of-twist1-and-its-methylation-in-bladder-urothelial-carcinoma-research-summary","Potential role of TWIST1 and its methylation in bladder urothelial carcinoma - Research summary","","Bladder urothelial carcinoma (BLCA) is driven by genetic and epigenetic alterations, and TWIST1 is an epithelial–mesenchymal transition (EMT) promoter implicated in multiple malignancies. This study integrates transcriptional expression and DNA methylation analyses across TCGA, GEO, UALCAN, GEPIA2, LinkedOmics, cBioPortal, MethSurv, and DNMIVD, then links results to prognosis and immune infiltration using GSCA and TISIDB. TWIST1 expression is down-regulated and inversely associated with methylation; promoter hypermethylation relates to progression, staging, grading, and recurrence, with CpG-site patterns supporting recurrence monitoring.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/potential-role-of-twist1-and-its-methylation-in-bladder-urothelial-carcinoma-research-summary/342213/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/potential-role-of-twist1-and-its-methylation-in-bladder-urothelial-carcinoma-research-summary/342213.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study on TWIST1 in BLCA?","Question",{"text":113,"@type":114},"To clarify the potential role of TWIST1 promoter methylation-related changes in bladder urothelial carcinoma and its connections to expression patterns and immune infiltration.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does TWIST1 expression relate to DNA methylation in BLCA?",{"text":118,"@type":114},"TWIST1 expression is down-regulated in BLCA and is negatively correlated with DNA methylation.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is TWIST1 promoter hypermethylation considered useful clinically?",{"text":122,"@type":114},"TWIST1 promoter hypermethylation is highly significantly associated with BLCA progression, staging, grading, and recurrence, and can serve as a biomarker for monitoring recurrence, especially using specific CpG site methylation status.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},342213,1790168475,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Potential role of TWIST1 and its methylation in bladder urothelial carcinoma  \nMeixuan Wan1\\#, Hongxue Meng1,2\\#, Huining Li3  \n1Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, China; 2Department of Precision Medicine Center, Harbin Medical University Cancer Hospital, Harbin, China; 3Department of Pathology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China  \nContributions: (I) Conception and design: M Wan, H Li; (II) Administrative support: None; (III) Provision of study materials or patients: H Meng, H Li; (IV) Collection and assembly of data: M Wan; (V) Data analysis and interpretation: M Wan, H Meng; (VI) Manuscript writing: All authors;  \n(VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work as co-first authors.  \nCorrespondence to: Huining Li, MMed. Department of Pathology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, 26 Heping Road, Xiangfang District, Harbin 150040, China. Email: [guzi_ye@163.com](guzi_ye@163.com).  \nBackground: Bladder urothelial carcinoma (BLCA), like other cancers, is strongly associated with genetic and epigenetic changes. TWIST1 is an epithelial-mesenchymal transition (EMT) promoter that has been linked to the development of many malignancies. It is still unclear, however, what role TWIST1 plays in BLCA, and the relationship between TWIST1 transcript levels and its promoter methylation and immune infiltration has been reported even less. This study aimed to reveal the potential role of TWIST1 promoter  \nmethylation-related changes in BLCA.  \nMethods: Transcriptional expression data of TWIST1 in BLCA were acquired from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and University of Alabama at Birmingham (UALCAN) databases. TWIST1 methylation levels and prognosis were sourced from Gene Expression Profiling Interactive Analysis 2 (GEPIA2), LinkedOmics, cBio Cancer Genomics Portal (c-BioPortal), MethSurv, and DNA Methylation Information Visualization Database (DNMIVD) databases. The methylation status of the BLCA-associated TWIST1 in preoperative and postoperative urinary exfoliated cells was subsequently analyzed using methylation-specific real-time fluorescence polymerase chain reaction, with validation of accuracy through pyrophosphate sequencing. Finally, from the Gene Set Cancer Analysis (GSCA) and Tumor-Immune System Interaction Database (TISIDB) databases, we obtained the association between TWIST1 transcript expression and DNA methylation and cancer immune infiltration and immunolabelling.  \nResults: Our study demonstrated that TWIST1 expression was down-regulated in BLCA, which was negatively correlated with DNA methylation. The association between TWIST1 promoter hypermethylation and the progression, staging, grading, and recurrence of BLCA is highly significant. Furthermore, we revealed that hypermethylation of both the preoperative and postoperative TWIST1 promoters is useful as a biomarker for monitoring BLCA recurrence, particularly when considering the methylation status of specific CpG sites. Additionally, we observed that TWIST1 expression, promoter methylation, and immune  \ninfiltration immunoreactive markers correlated significantly in BLCA.  \nConclusions: We propose that TWIST1 holds great promise as a diagnostic and therapeutic target for BLCA, with the potential to influence tumor progression and patient prognosis through the regulation of immune cell infiltration. We hope these findings contribute valuable insights to the field of BLCA research.  \nKeywords: Bladder urothelial carcinoma (BLCA); TWIST1; methylation; epigenetics; prognosis  \nSubmitted Jun 20, 2024. Accepted for publication Sep 29, 2024. Published online Nov 21, 2024.  \ndoi: 10.21037/tcr-24-1029  \nView this article at: [https://dx.doi.org/10.21037/tcr-24-1029](https://dx.doi.org/10.21037/tcr-24-1029)  \n© AME Publishing Company. Transl Cancer Res 2024;13","cbCairvSvrYVnWY9","https://ap.wps.com/l/cbCairvSvrYVnWY9","pdf",2079916,17,"English","# Introduction\n## Background and rationale\n# Methods\n## Data sources and methylation analysis\n## Immune infiltration association\n# Results\n## TWIST1 expression and methylation relationship\n## Prognostic and recurrence biomarker value\n## Correlation with immune markers\n# Conclusions","[{\"question\":\"What is the main objective of the study on TWIST1 in BLCA?\",\"answer\":\"To clarify the potential role of TWIST1 promoter methylation-related changes in bladder urothelial carcinoma and its connections to expression patterns and immune infiltration.\"},{\"question\":\"How does TWIST1 expression relate to DNA methylation in BLCA?\",\"answer\":\"TWIST1 expression is down-regulated in BLCA and is negatively correlated with DNA methylation.\"},{\"question\":\"Why is TWIST1 promoter hypermethylation considered useful clinically?\",\"answer\":\"TWIST1 promoter hypermethylation is highly significantly associated with BLCA progression, staging, grading, and recurrence, and can serve as a biomarker for monitoring recurrence, especially using specific CpG site methylation status.\"}]","Potential role of TWIST1 and its methylation in bladder urothelial carcinoma - Research summary | PDF",1790045798,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17ab3b5c52551898afa7ef3b861884df.webp",983,1287,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45e48d9770f9f436a67019a79918232d.webp",982,1286,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4bfd8c7d1aef9fc1942e90fa09a5f4d8.webp",981,1284,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4021e854b10d43280e62d89ca4805a67.webp",980,1283]